Biological Sample Repository for Gastrointestinal Disorders

SuspendedOBSERVATIONAL
Enrollment

500

Participants

Timeline

Start Date

July 19, 2023

Primary Completion Date

July 31, 2028

Study Completion Date

April 30, 2029

Conditions
ObesityObesity, MorbidObesity, PrimaryGastro-Intestinal DisorderOverweight and ObesityOverweightOverweight or ObesityDiabetes Type 2Diabetes MellitusDiabetes Mellitus, Type 2HypertensionHyperlipidemiasSleep ApneaGERDGastroesophageal RefluxMusculoskeletal Pain DisorderCancer
Interventions
DIAGNOSTIC_TEST

Blood Collection

Blood collection via venipuncture

DIAGNOSTIC_TEST

Urine Collection

Free catch urine sample collection

DIAGNOSTIC_TEST

Tissue Sample Collection

Tissue (gastric, duodenum, jejunum and ileum - number of biopsies will be 3-4 from each site, ranging in size from 4-7mm) - These samples collected will be extra biopsies that are taken for research purposes during a clinically planned endoscopy for which biopsies are being planned.

Trial Locations (1)

02115

Brigham and Women's Hospital, Boston

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Tufts University

OTHER

collaborator

Boston Children's Hospital

OTHER

collaborator

Mayo Clinic

OTHER

lead

Pichamol Jirapinyo, MD, MPH

OTHER

NCT05874726 - Biological Sample Repository for Gastrointestinal Disorders | Biotech Hunter | Biotech Hunter